SPY335.57+1.00 0.30%
DIA278.14+3.52 1.28%
IXIC10,968.36-42.63 -0.39%

FSD Pharma Says Working to Submit IND to FDA for the Use of FSD201 to Treat Hospitalized COVID-19 Patients

FSD Pharma Inc. (NASDAQ: HUGE) (CSE:HUGE.CN) (FRA:0K9A) ("FSD Pharma" or the "Company") today announced that it has notified Health Canada of the Company's decision to forfeit the licenses of its wholly-owned subsidiary, FV Pharma, Inc.

Benzinga · -